Senior Specialist, QC Analytical, Cell Therapy at Bristol-Myers Squibb

Devens, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor's degree or equivalent required, preferably in science (Netherlands: Bachelor's degree / HLO in (bioanalytical) science required)
4+ years of relevant analytical testing or QC experience or equivalent combination of education and experience, preferably in a regulated environment
Demonstrated experience in cell and molecular biology techniques (e.g., cell-based assays, flow cytometry, qPCR, ELISA, and aseptic technique)
Ability to accurately and completely understand, follow, interpret and apply Global Regulatory and cGMP requirements
Demonstrated technical writing skills
High problem-solving ability/mentality, technically adept and logical
Ability to communicate effectively with peers, department management and cross-functional peers about task status, roadblocks and needs
Ability to work in a fast-paced team environment, meet deadlines, and prioritize work
Advanced knowledge of LIMS, ELN and laboratory data analysis systems preferred

Responsibilities

Perform method transfer/validation and routine testing of in-process, final product, and stability samples
Anticipate and perform routine troubleshooting and problem solving with minimal guidance
Perform data verification, data review and review of GMP documentation for general and complex methods
Perform document revision, project, CAPA and deviation/investigation related tasks and/or continuous improvement efforts
Train and mentor others on QC test methods, processes and procedures
Perform other tasks as assigned

Skills

QC Analytical

Method Transfer

Method Validation

GMP Documentation

Data Review

Data Verification

Troubleshooting

CAPA

Deviations

Investigations

Cell Therapy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free